Urge your members of Congress to support continued medical research funding
Listen to Drs. Marquita Nelson, Jori May, and Nicole Cruz discuss important sessions, events, and features that could benefit the trainee community at this year’s annual meeting.
Good research should be recognized, funded, and advanced. ASH provides funding and training opportunities through various awards for trainees and early-career investigators in the field of hematology. As trainees, getting awards not only builds our CVs and enhances our careers. It also gives us opportunities to think in-depth on research projects and career directions.
When you move on from PhD student to post-doc or transition from clinical to research fellow, chances are that your workplace and responsibilities will change significantly. Here are some tips and tricks for dealing with these changes and familiarize yourself with your new research job as soon as possible.
Each transition in your medical career has been full of unique challenges that you have mastered to get where you are today. As you acclimate to your new role, here are a few recommendations.
Hematology trainees on the physician-scientist track know quite well the challenges to navigating a career in science and medicine. The physician-scientist track is filled with transitions from the bench to bedside and back.
The way forward from postdoc to principal investigator (PI) is diverse and complicated. Here we share some reflections from Ze and Andrew who are in the process of becoming independent, and Jeremy who has recently started his own independent lab.
We asked the fellows who joined the ASH Trainee Council in 2018 why someone should apply to be part of the council.
“The Trainee Council represents an invaluable opportunity to learn from and be a part of a larger community of hematologists. My experience has been eye-opening
I remember when I realized that my predoctoral training was coming to an end. It was 2014, and the recent National Institutes of Health (NIH) workforce study portended a bleak outlook for newly minted PhDs. I therefore felt justified in telling my dissertation committee chair that
Sickle cell disease (SCD) in the adult population has been an understudied and underappreciated topic compared to other hematologic conditions. Lack of awareness of gaps in the SCD field stems largely from the fact that SCD is frequently considered a primarily pediatric condition.
Sickle cell disease (SCD) affects a profound number of people worldwide, including approximately 100,000 people in the United States. One in 365 black infants have SCD, and one in 13 have sickle cell trait. The field of pediatric SCD care has grown significantly and achieved numer
Access an extensive online library of screen-sized blood disease images and cases for educational use.
Apply for one of the many hematology awards and training programs offered by ASH to support hematologists in all stages of their careers.
Download The Hematologist app for on-the-go access to ASH's official member newsletter. Now available for iOS and Android devices.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology